Zoetis Belgium S.A.

Form 483 issued November 22, 2022 · Ottignies-Louvain-la-Neuve, Belgium

Inspection
Nov 14 – Nov 22, 2022
Investigator
Jose M. Cayuela
Observations
5
Pages
15
FEI number
3010087842

In short: On November 22, 2022, FDA issued a Form 483 with 5 observations to Zoetis Belgium S.A. in Ottignies-Louvain-la-Neuve, Belgium (FEI 3010087842) after an inspection that ran Nov 14 – Nov 22, 2022. The investigator was Jose M. Cayuela. Most observations concern production and quality system.

At a glance

Production and quality system account for 4 of 5 observations.

Production2
Quality system2
Laboratory controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be…

  2. 02

    The written stability testing…

  3. 03

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

  4. 04

    Your firm failed to establish adequate written procedures for production and process controls designed to assure…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Zoetis Belgium S.A.?

FDA listed 5 observations on this Form 483, mostly about production, quality system and laboratory controls. The opening words of each observation are shown on this page.

Who inspected Zoetis Belgium S.A.?

Jose M. Cayuela is named on this Form 483, for the inspection of Nov 14 – Nov 22, 2022. Each investigator has a profile showing what they cite most.

When was Zoetis Belgium S.A. inspected by FDA?

The inspection ran Nov 14 – Nov 22, 2022, and the Form 483 is dated November 22, 2022.

How do I get the full Form 483 for Zoetis Belgium S.A.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free